A laccase with antiproliferative and HIV-I reverse transcriptase inhibitory activities from the mycorrhizal fungus Agaricus placomyces

J Biomed Biotechnol. 2012:2012:736472. doi: 10.1155/2012/736472. Epub 2012 Oct 3.

Abstract

A novel 68 kDa laccase was purified from the mycorrhizal fungus Agaricus placomyces by utilizing a procedure that comprised three successive steps of ion exchange chromatography and gel filtration as the final step. The monomeric enzyme exhibited the N-terminal amino acid sequence of DVIGPQAQVTLANQD, which showed only a low extent of homology to sequences of other fungal laccases. The optimal temperature for A. placomyces laccase was 30°C, and optimal pH values for laccase activity towards the substrates 2,7'-azinobis[3-ethylbenzothiazolone-6-sulfonic acid] diammonium salt (ABTS) and hydroquinone were 5.2 and 6.8, respectively. The laccase displayed, at 30°C and pH 5.2, K(m) values of 0.392 mM towards hydroquinone and 0.775 mM towards ABTS. It potently suppressed proliferation of MCF 7 human breast cancer cells and Hep G2 hepatoma cells and inhibited human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity with an IC(50) of 1.8 μM, 1.7 μM, and 1.25 μM, respectively, signifying that it is an antipathogenic protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agaricus / enzymology*
  • Cell Proliferation / drug effects
  • Fungal Proteins / metabolism
  • Fungal Proteins / pharmacology
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • Hep G2 Cells
  • Humans
  • Laccase / administration & dosage*
  • Laccase / metabolism*
  • MCF-7 Cells
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / pathology
  • Reverse Transcriptase Inhibitors / chemistry*

Substances

  • Fungal Proteins
  • Reverse Transcriptase Inhibitors
  • Laccase
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase